Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307135/
https://www.ncbi.nlm.nih.gov/pubmed/37387809
http://dx.doi.org/10.1155/2023/9808196
_version_ 1785065975746396160
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10307135
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103071352023-06-29 Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307135/ /pubmed/37387809 http://dx.doi.org/10.1155/2023/9808196 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function
title Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function
title_full Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function
title_fullStr Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function
title_full_unstemmed Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function
title_short Retracted: Efficacy of Fluticasone and Salmeterol Dry Powder in Treating Patients with Bronchial Asthma and Its Effect on Inflammatory Factors and Pulmonary Function
title_sort retracted: efficacy of fluticasone and salmeterol dry powder in treating patients with bronchial asthma and its effect on inflammatory factors and pulmonary function
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307135/
https://www.ncbi.nlm.nih.gov/pubmed/37387809
http://dx.doi.org/10.1155/2023/9808196
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retractedefficacyoffluticasoneandsalmeteroldrypowderintreatingpatientswithbronchialasthmaanditseffectoninflammatoryfactorsandpulmonaryfunction

Ejemplares similares